Following last week’s Israeli cancer breakthrough (see here), now Weizmann Institute researchers have found an antibody (against CD84) that prevents tumors building molecular bridges from suppressing the immune system. Lab tests were successful at treating triple-negative breast cancer.

https://www.jns.org/israeli-antibody-treatment-targets-most-aggressive-breast-cancer/#:

https://wis-wander.weizmann.ac.il/life-sciences/burning-cancer%E2%80%99s-bridges

https://www.cell.com/cell-reports/fulltext/S2211-1247(24)01271-3#fig1